Page 9 - Johnson & Johnson

J&J pays Rs 25 lakh each to three victims in UP for faulty hip implants

Pharmaceutical Major Johnson & Johnson said it has paid Rs 25 lakh each to three victims of its faulty acetabular surface replacement (ASR) hip implants in Uttar Pradesh. According to Uttar Pradesh Drug Licensing and Control officer A K Jain, the company has given compensation to three patients who had undergone revision surgeries for the faulty implants made by the company. The Delhi High Court had in May directed Johnson and Johnson to make an interim payment of Rs 25 lakh each to the 67 patients who have undergone revision surgeries. Jain said the Uttar Pradesh Drug Licensing and Control Authority was promptly following such complaints.

J&J denies withholding interim compensation for faulty hip implants

However, the central government told the court that the company till date has paid the interim compensation to only 67 patients out of the over 4,700 persons

J&J to pay Rs 25 lakh each to 67 victims of faulty ASR hip implants

J&J says it will pay other patients only if they fulfil criteria set by company

J&J's largest India plant idle for 3 yrs, hurts govt's employment campaign

The groundbreaking of the J&J facility in Telangana's Penjerla, its third in the country, was carried out with much fanfare in 2014.

No formaldehyde in baby shampoo: J&J rejects Rajasthan govt report

Johnson & Johnson has strongly rejected findings of a Rajasthan government laboratory showing presence of "harmful" chemicals in the US-based company's baby shampoo, a popular product in India. Based on the report of the Drug Testing Laboratory in Jaipur, the National Commission for Protection of Child Rights (NCPCR) has written to the chief secretaries of all states and Union Territories asking them to stop sale of Johnson & Johnson's (J&J) baby shampoo and remove it from the stocks. The NCPCR said the test report found presence of formaldehyde in J&J's baby shampoo. The company, in a statement, said it has not received any direction to stop the sale of its shampoo and that it was not accepting the interim results of the laboratory tests which were based on "unknown and unspecified" methods. India is a major market for J&J globally, and its share in the country's Rs 4,000-crore baby care market is nearly three-fourths. "We will await the results and conclusions of

Child rights body asks states to stop sale of Johnson's baby shampoo

Its sample was found to be of substandard quality in a lab test

J&J tries to use supplier bankruptcy to fight 2,400 baby-powder lawsuits

J&J is facing more than 14,000 claims its talc products caused ovarian cancer or mesothelioma, a rare cancer linked to asbestos exposure. The company denies its products ever contained the carcinogen

J&J moves Delhi HC, says willing to pay only Rs 25 lakh to victims

The company said it was willing to pay Rs 25 lakh as compensation to those affected but could not agree to the arbitrary amounts being imposed by the government

Johnson & Johnson wins trial over California man's talc-cancer claims

J&J is facing more than 13,000 lawsuits linking baby powder and another talc product

Does J&J's 'No More Tears' baby shampoo contain cancer-causing substance?

Rajasthan's drug controller found that Johnson & Johnson baby shampoo samples were not of standard quality

J&J's baby shampoo samples are not of standard quality: Drug controller

This comes after J&J's hip implants and baby powder were declared defective

Govt order asking J&J to pay compensation is complete hogwash: Expert

In November, the government had come up with a compensation formula based on factors such as age, risk and percentage of disability

US court awards $29 mn to cancer victim who alleged J&J talcum had asbestos

(Reuters) - A California jury on Wednesday awarded $29 million to a woman who said that asbestos in Johnson & Johnson's talcum-powder-based products caused her cancer.

J&J asked to pay Rs 74.5 lakh to first patient with faulty hip implant

Based on the recommendations of the central expert committee and the state-level committee, the Central Drugs Standard Control Organisation (CDSCO) has directed Johnson and Johnson to pay Rs 74,57,180 to the first patient from Mumbai who received faulty hip implants made by the company. This is the first case where M/s Johnson & Johnson has been directed to pay compensation for its faulty ASR hip implants manufactured and imported by M/s DePuy International Limited (now Johnson & Johnson Pvt Ltd). The CDSCO has directed the compensation to be paid within 30 days from the date of receipt of the order. In November last year, the Union Health Ministry approved a formula for determination of compensation for patients who had received, prior to August 2010, ASR hip implants manufactured by DePuy International Limited, U.K of J&J. According to the formula, thousands of patients implanted with US pharmaceutical major Johnson and Johnson's (J&J) articular surface replacement ..

Govt directs J&J to pay Rs 74 lakh to first victim of faulty hip implant

The expert committee had earlier suggested that patients should be paid based on the disability caused

J&J to add prices to TV ads making drug prices transparent for consumers

CHICAGO (Reuters) - Johnson & Johnson said on Thursday it will start adding the price of its medicines to television commercials by next month, becoming the first drugmaker to heed a call by U.S. President Donald Trump for price transparency of drugs advertised directly to consumers on TV.

$120 mn: Cost Johnson & Johnson will pay to settle hip-implant claims in US

(Reuters) - Johnson & Johnson and its DePuy Orthopaedics unit have agreed to pay $120 million to resolve deceptive marketing claims by several U.S. states over the company's metal-on-metal hip implants.

SC accepts govt response on compensation for J&J hip implant victims

Panel had recommended compensation of up to Rs 1.22 crore for victims

Take action against J&J over faulty hip implants: 10 MPs write to Nadda

Ten MPs, seven of them belonging to BJP ally Shiv Sena, have written to Union Health Minister J P Nadda to take "appropriate action" against global healthcare major Johnson and Johnson (J&J) and "ensure justice for all sufferers" of faulty ASR hip implants. Union Minister of State for Health and Family Welfare Anupriya Patel, who belongs to BJP ally Apna Dal(Sonelal), is among the 10 MPs to have written to Nadda. "Most recently, the company (J&J) seems to be going against the government's directions and denying its liability in compensating patients," Chandrakant Khaire, Shiv Sena MP from Aurangabad in Maharashtra, wrote in a letter dated January 7. "I call upon you 'sir' (Nadda) to independently identify all patients who have received the faulty ASR implants in India; and take appropriate action/s against the company to ensure that justice is met to all the sufferers of these faulty ASR (hip) implants (sic)," Khaire added. In December last year, J&J had approached the ...

India orders Johnson & Johnson to stop using raw material for Baby Powder

US company asked to stop using the 'huge quantities' of raw materials stocked in its plants in northern and western India.